Researchers from the University of Florida Gainesville showed last December that hospitalised patients who seemingly recovered from severe COVID-19 run more than double the risk of dying within the next year, compared to people who experienced only mild or moderate symptoms and who had not been hospitalised, or who never caught the illness.
The NHS is rolling out a cutting-edge, life-saving COVID treatment, which is proven to save lives when given to the most seriously ill COVID patients in hospital.
Researchers from Queen Mary University of London have combined evidence from 110 previous COVID-19 studies and found that unvaccinated individuals who contract the virus when they already have high blood pressure, diabetes or major heart damage are up to nine times more likely to suffer serious outcomes, including death, lung failure, admission to intensive care and kidney problems.
An online breathing and wellbeing programme helps improve quality of life and breathlessness for people recovering from COVID-19, according to a new study.
High blood pressure and treatments to control it do not increase the risk of hospitalisation and death from Covid-19, according to a large European-wide study which in the UK was co-ordinated at UCLH and UCL.
Thousands more vulnerable people in England are now eligible to receive the UK’s second oral antiviral treatment for COVID-19.
A research team led by Jae Jung, PhD, Director of Cleveland Clinic’s Global Center for Pathogen & Human Health Research, has uncovered the critical role a viral gene, ORF8, plays in infection and disease outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.
A study from Sweden published by The BMJ has found an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after COVID-19 infection, pulmonary embolism (a blood clot in the lung) up to six months, and a bleeding event up to two months.
Regulations making COVID-19 vaccination a condition of deployment in health and social care will be revoked on Tuesday 15 March, the Health and Social Care Secretary has confirmed.
Scientists at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C).
The NHS Confederation's chief executive, Matthew Taylor, and other health leaders, have raised concerns over the Government's 'Living with COVID-19' strategy.
A new study has confirmed that vitamin D levels may positively influence the outcome of COVID-19 infection.
Adults over the age of 50 or with an underlying health condition who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving antivirals to thousands of people.
Allowing large numbers of people in low and middle-income countries to go unvaccinated is “a reckless approach to public health” that could lead to new variants of Coronavirus, scientists have warned.
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in September 2021 and supported by the NIHR, has released positive data.
An international team of scientists have identified antibodies that neutralise omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses.